Day 2 - Friday, 17 April 2020
Session 1: Glomerulonephritis (8am)
Management of nephrotic syndrome for non-nephrologists - Manuel Praga; Spain
IgA nephropathy - Daniel Cattran; Canada
Evidence based management of lupus nephritis: recent clinical trials and updated guidelines - David Jayne; UK
Break
Session 2: Glomerulonephritis/ Vasculitis (9.50am)
Membranous Nephropathy - Daniel Cattran; Canada
The diagnosis and management of ANCA associated vasculitis - David Jayne; UK
Primary and secondary aHUS - differential diagnosis and treatment - Manuel Praga; Spain
Lunch Break
Session 3: Hypertension/ CKD (12.50pm)
Diabetic Kidney Disease: Hypertension control - David Wheeler; UK
Role of GLP1 receptor agonists in diabetes and DKD – Peter Rossing; Denmark
SGLT2 inhibitors and CV and renal outcomes in type 2 diabetes - David Wheeler; UK
KDIGO guideline for CKD in diabetes - Peter Rossing; Denmark
Break
Session 4: Parallel workshops (3.15pm)
a) Nephro-pathology Workshop - Mohammed Akhtar; Qatar & David Jayne; UK
b) Dialysis workshop: Anemia/ Mineral Bone Disease - David Wheeler; UK
Session 5: Oral Presentations (4.30pm)
Break
Session 6: Dialysis for ESRD (6.20pm)
HD; One size does not fit all - Roger Greenwood; UK
PD: Limiting complication and increasing survival in the early dialysis period - Stanley Fan; UK
Dialysis on the move – Roger Greenwood; UK
PD/HD Debate – Roger Greenwood & Stanley Fan; UK
Dinner
